199 related articles for article (PubMed ID: 56780)
1. Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement).
Alper CA; Balavitch D
Science; 1976 Mar; 191(4233):1275-6. PubMed ID: 56780
[TBL] [Abstract][Full Text] [Related]
2. Complement in the serum and venom of Brazilian snakes (Crotalidae).
Dias da Silva W; Calich VL; Kipnis TL; Rosen FS; Alper CA
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():97-103. PubMed ID: 6587747
[TBL] [Abstract][Full Text] [Related]
3. Antigenic relationships between human and cobra complement factors C3 and cobra venom factor (CVF) from the Indian cobra (Naja naja).
Eggertsen G; Lundwall A; Hellman U; Sjöquist J
J Immunol; 1983 Oct; 131(4):1920-3. PubMed ID: 6194220
[TBL] [Abstract][Full Text] [Related]
4. Preparation of complement fragments C3b and C3a from purified rat complement component C3 by activated cobra venom factor.
Usami M; Ohno Y
J Pharmacol Toxicol Methods; 2005; 52(2):260-3. PubMed ID: 16125624
[TBL] [Abstract][Full Text] [Related]
5. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
6. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
Hew BE; Fritzinger DC; Pangburn MK; Vogel CW
Toxicon; 2019 Sep; 167():106-116. PubMed ID: 31207349
[TBL] [Abstract][Full Text] [Related]
7. Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability.
Hew BE; Pangburn MK; Vogel CW; Fritzinger DC
Toxicon; 2020 Sep; 184():68-77. PubMed ID: 32526239
[TBL] [Abstract][Full Text] [Related]
8. Recombinant cobra venom factor.
Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of recombinant cobra venom factor.
Kock MA; Hew BE; Bammert H; Fritzinger DC; Vogel CW
J Biol Chem; 2004 Jul; 279(29):30836-43. PubMed ID: 15131128
[TBL] [Abstract][Full Text] [Related]
10. The failure to show a necessary role for C3 in the in vitro antibody response.
Waldmann H; Lachmann PJ
Eur J Immunol; 1975 Mar; 5(3):185-93. PubMed ID: 1086224
[TBL] [Abstract][Full Text] [Related]
11. Immunological, structural and functional relationships between an anti-complementary protein from Crotalus atrox venom, cobra venom factor and human C3.
Minta JO; Man D
Immunology; 1980 Apr; 39(4):503-9. PubMed ID: 6769786
[TBL] [Abstract][Full Text] [Related]
12. A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor.
O'Keefe MC; Caporale LH; Vogel CW
J Biol Chem; 1988 Sep; 263(25):12690-7. PubMed ID: 3045125
[TBL] [Abstract][Full Text] [Related]
13. Complement-dependent B-cell activation by cobra venom factor and other mitogens?
Dukor P; Schumann G; Gisler RH; Dierich M; König W; Hadding U; Bitter-Suermann D
J Exp Med; 1974 Feb; 139(2):337-54. PubMed ID: 4589989
[TBL] [Abstract][Full Text] [Related]
14. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
[TBL] [Abstract][Full Text] [Related]
15. The effects of complement activation by cobra venom factor on the migration of T and B lymphocytes into rat thoracic duct lymph.
Spry CJ; Lane JT; Vyakarnam A
Immunology; 1977 Jun; 32(6):947-54. PubMed ID: 301855
[TBL] [Abstract][Full Text] [Related]
16. Isolation and properties of a complement inhibitor from Naja haje venom, distinct from known anticomplementary factors in cobra venom.
von Zabern I; Przyklenk H; Damerau B; Zimmermann B
Scand J Immunol; 1981 Aug; 14(2):109-20. PubMed ID: 6914809
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
Fritzinger DC; Hew BE; Thorne M; Pangburn MK; Janssen BJ; Gros P; Vogel CW
Dev Comp Immunol; 2009; 33(1):105-16. PubMed ID: 18760301
[TBL] [Abstract][Full Text] [Related]
18. Cobra venom factor: structural homology with the third component of human complement.
Vogel CW; Smith CA; Müller-Eberhard HJ
J Immunol; 1984 Dec; 133(6):3235-41. PubMed ID: 6491285
[TBL] [Abstract][Full Text] [Related]
19. The cobra complement system: I. The alternative pathway of activation.
Vogel CW; Müller-Eberhard HJ
Dev Comp Immunol; 1985; 9(2):311-25. PubMed ID: 3894085
[TBL] [Abstract][Full Text] [Related]
20. [A new low molecular-weight protein effector of human complement from the venom of the Central Asian cobra Naja naja oxiana].
Kozlov LV; Soliakov LS; Zinchenko AA
Bioorg Khim; 1984 Mar; 10(3):323-32. PubMed ID: 6567467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
